Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients
Pheochromocytomas and paragangliomas (PHEO/PGL) are rare but occasionally life-threatening neoplasms, and are potentially malignant according to WHO classification in 2017. However, it is also well known that histopathological risk stratification to predict clinical outcome has not yet been establis...
Main Authors: | Yuto Yamazaki, Xin Gao, Alessio Pecori, Yasuhiro Nakamura, Yuta Tezuka, Kei Omata, Yoshikiyo Ono, Ryo Morimoto, Fumitoshi Satoh, Hironobu Sasano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.587769/full |
Similar Items
-
Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma
by: Xin Gao, et al.
Published: (2020-11-01) -
Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
by: Hye-Ryeon Choi, et al.
Published: (2021-07-01) -
Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
by: Trisha Dwight, et al.
Published: (2017-07-01) -
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
by: Balazs Sarkadi, et al.
Published: (2020-03-01) -
Targeting NRF2-Governed Glutathione Synthesis for <i>SDHB</i>-Mutated Pheochromocytoma and Paraganglioma
by: Yang Liu, et al.
Published: (2020-01-01)